1-3 of 3
Christoffer Gebhardt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Benjamin Weide, Alexander Martens, Jessica C. Hassel, Carola Berking, Michael A. Postow, Kees Bisschop, Ester Simeone, Johanna Mangana, Bastian Schilling, Anna Maria Di Giacomo, Nicole Brenner, Katharina Kähler, Lucie Heinzerling, Ralf Gutzmer, Armin Bender, Christoffer Gebhardt, Emanuela Romano, Friedegund Meier, Peter Martus, Michele Maio, Christian Blank, Dirk Schadendorf, Reinhard Dummer, Paolo A. Ascierto, Geke Hospers, Claus Garbe, Jedd D. Wolchok
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (22): 5487–5496.
https://doi.org/10.1158/1078-0432.CCR-16-0127
Published: 14 November 2016
View article titled, Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
Open the PDF for Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab in another window
Includes: Supplementary data
Journal Articles

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

Christoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, Ramtin Lichtenberger, Maike Reith, Kathrin Tarnanidis, Tim Holland-Letz, Ludmila Umansky, Philipp Beckhove, Antje Sucker, Dirk Schadendorf, Jochen Utikal, Viktor Umansky
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5453–5459.
https://doi.org/10.1158/1078-0432.CCR-15-0676
Published: 14 December 2015
View article titled, Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Open the PDF for Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab in another window
Includes: Supplementary data
Journal Articles

Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter

Mathias Bernhardt, Elias Orouji, Lionel Larribere, Christoffer Gebhardt, Jochen Utikal
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2498–2499.
https://doi.org/10.1158/1078-0432.CCR-13-2349
Published: 30 April 2014
View article titled, Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
Open the PDF for Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter in another window